Business
OXB to present at the Leerink Partners Global Healthcare Conference
OXB to present at the Leerink Partners Global Healthcare Conference Oxford, UK – 26 February 2025: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces that Dr. Lucinda Crabtree, Chief Financial Officer, will take part in a fireside chat at the Leerink Partners Global Healthcare Conference in Miami, Florida on Tuesday, 11 March 2025 at 2:20 PM EDT / 6:20 PM GMT. A live webcast of the fireside chat will be available on the ‘Investor Relations’ section of
About this update from Oxford Biomedica Plc
[{"type":"image","alt":"OXB","displaySize":"","headline":null,"caption":"OXB","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":159,"url":"https://media.zenfs.com/en/globenewswire.com/c14d9d68668513a9042681f5e1f388c2"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/fa8vdAQ1u36jC9pq9QpcgQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIyMztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/c14d9d68668513a9042681f5e1f388c2","width":300,"height":159}},"lazy":false},{"type":"text","content":"OXB to present at the Leerink Partners Global Healthcare Conference ","length":67,"tagName":"p","attribs":{}},{"type":"text","content":"Oxford, UK – 26 February 2025: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces that Dr. Lucinda Crabtree, Chief Financial Officer, will take part in a fireside chat at the Leerink Partners Global Healthcare Conference in Miami, Florida on Tuesday, 11 March 2025 at 2:20 PM EDT / 6:20 PM GMT.","length":344,"tagName":"p"},{"type":"text","content":"A live webcast of the fireside chat will be available on the ‘Investor Relations’ section of OXB’s website under ‘Results, Reports, Presentations & Webcasts’ at www.oxb.com. A replay will be accessible following the event.","length":226,"tagName":"p"},{"type":"text","content":"-Ends-","length":6,"tagName":"p"},{"type":"text","content":"Enquiries:","length":10,"tagName":"p"},{"type":"text","content":"OXB:","length":4,"tagName":"p","attribs":{}},{"type":"text","content":"Sophia Bolhassan, Head of Investor Relations – T: +44 (0) 1865 509 737 / E: [email protected]","length":86,"tagName":"p","attribs":{}},{"type":"text","content":"ICR Healthcare:T: +44 (0)20 3709 5700 / E: [email protected]","length":70,"tagName":"p","attribs":{}},{"type":"text","content":"Mary-Jane Elliott / Angela Gray / Davide Salvi","length":46,"tagName":"p"},{"type":"text","content":"About OXB","length":9,"tagName":"p"},{"type":"text","content":"OXB (LSE: OXB) is a global quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life changing therapies to patients around the world.","length":239,"tagName":"p","attribs":{}},{"type":"text","content":"One of the original pioneers in cell and gene therapy, OXB has 30 years of experience in viral ...